Ador Multi Products Ltd
Incorporated in 1986, Ador Multiproducts Ltd manufactures and distributes cosmetic and personal care products[1]
- Market Cap ₹ 14.8 Cr.
- Current Price ₹ 31.8
- High / Low ₹ 45.9 / 27.6
- Stock P/E
- Book Value ₹ 4.90
- Dividend Yield 0.00 %
- ROCE -7.00 %
- ROE -9.33 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company's working capital requirements have reduced from 58.6 days to 16.3 days
Cons
- Stock is trading at 6.48 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -6.69% over past five years.
- Promoter holding is low: 38.6%
- Company has a low return on equity of -9.25% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11.59 | 9.93 | 8.16 | 5.79 | 6.55 | 6.57 | 7.28 | 8.26 | 17.57 | 7.21 | 5.89 | 5.15 | 2.41 | |
12.02 | 11.22 | 8.91 | 6.57 | 7.43 | 7.35 | 8.56 | 8.67 | 15.61 | 7.83 | 7.49 | 5.65 | 2.94 | |
Operating Profit | -0.43 | -1.29 | -0.75 | -0.78 | -0.88 | -0.78 | -1.28 | -0.41 | 1.96 | -0.62 | -1.60 | -0.50 | -0.53 |
OPM % | -3.71% | -12.99% | -9.19% | -13.47% | -13.44% | -11.87% | -17.58% | -4.96% | 11.16% | -8.60% | -27.16% | -9.71% | -21.99% |
0.04 | 0.05 | 0.05 | 0.14 | 2.21 | 0.16 | 0.18 | 0.31 | 4.44 | 0.30 | 0.03 | -9.58 | 0.03 | |
Interest | 0.06 | 0.08 | 0.20 | 0.32 | 0.33 | 0.20 | 0.07 | 0.13 | 0.06 | 0.03 | 0.11 | 0.14 | 0.12 |
Depreciation | 0.20 | 0.23 | 0.15 | 0.18 | 0.07 | 0.12 | 0.20 | 0.20 | 0.28 | 0.29 | 0.30 | 0.29 | 0.26 |
Profit before tax | -0.65 | -1.55 | -1.05 | -1.14 | 0.93 | -0.94 | -1.37 | -0.43 | 6.06 | -0.64 | -1.98 | -10.51 | -0.88 |
Tax % | -30.77% | -31.61% | -32.38% | -38.60% | 43.01% | 3.19% | -0.73% | -81.40% | 17.16% | 20.31% | -0.51% | -0.29% | |
-0.45 | -1.06 | -0.71 | -0.70 | 0.53 | -0.97 | -1.36 | -0.08 | 5.01 | -0.77 | -1.97 | -10.48 | -0.86 | |
EPS in Rs | -1.72 | -4.05 | -2.59 | -2.44 | 1.85 | -3.39 | -3.62 | -0.20 | 10.72 | -1.65 | -4.22 | -22.42 | -1.83 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -6% |
5 Years: | -7% |
3 Years: | -34% |
TTM: | -64% |
Compounded Profit Growth | |
---|---|
10 Years: | 3% |
5 Years: | 8% |
3 Years: | % |
TTM: | 67% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | -8% |
3 Years: | -27% |
1 Year: | -22% |
Return on Equity | |
---|---|
10 Years: | -9% |
5 Years: | -3% |
3 Years: | -9% |
Last Year: | -9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 2.61 | 2.61 | 2.74 | 2.86 | 2.86 | 2.86 | 3.76 | 3.96 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 |
Reserves | 2.03 | 0.97 | 0.35 | -0.32 | 2.97 | 1.99 | 3.17 | 3.79 | 11.22 | 10.47 | 8.50 | -1.97 | -2.38 |
0.78 | 0.86 | 2.14 | 2.32 | 2.40 | 0.50 | 0.59 | 1.50 | 0.00 | 0.23 | 1.12 | 1.02 | 0.88 | |
1.23 | 2.38 | 1.46 | 1.49 | 2.13 | 1.94 | 2.66 | 5.30 | 3.70 | 2.18 | 2.30 | 1.11 | 0.99 | |
Total Liabilities | 6.65 | 6.82 | 6.69 | 6.35 | 10.36 | 7.29 | 10.18 | 14.55 | 19.59 | 17.55 | 16.59 | 4.83 | 4.16 |
1.30 | 1.23 | 1.23 | 1.09 | 5.26 | 1.29 | 2.20 | 2.48 | 2.84 | 2.62 | 2.33 | 2.04 | 1.91 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.05 | 0.05 | 0.05 | 0.60 | 2.07 | 2.45 | 4.44 | 4.11 | 8.87 | 10.37 | 10.37 | 0.61 | 0.61 |
5.30 | 5.54 | 5.41 | 4.66 | 3.03 | 3.55 | 3.54 | 7.96 | 7.88 | 4.56 | 3.89 | 2.18 | 1.64 | |
Total Assets | 6.65 | 6.82 | 6.69 | 6.35 | 10.36 | 7.29 | 10.18 | 14.55 | 19.59 | 17.55 | 16.59 | 4.83 | 4.16 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.06 | 0.04 | 0.59 | -0.25 | 3.41 | -3.52 | -0.56 | -0.94 | -4.13 | 0.18 | -0.98 | -9.67 | |
-0.11 | -0.12 | -0.15 | 0.01 | -3.49 | 3.63 | -2.89 | 0.46 | 0.96 | -0.89 | 0.02 | 9.93 | |
-0.05 | 0.24 | -0.24 | -0.14 | 0.02 | 0.05 | 3.45 | 0.75 | 3.09 | -0.13 | -0.07 | -0.18 | |
Net Cash Flow | -0.22 | 0.16 | 0.20 | -0.38 | -0.07 | 0.16 | -0.01 | 0.26 | -0.07 | -0.85 | -1.03 | 0.08 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 83.77 | 86.75 | 80.51 | 67.45 | 64.64 | 87.22 | 65.68 | 94.12 | 30.75 | 57.71 | 66.31 | 13.47 |
Inventory Days | 56.82 | 56.96 | 65.99 | 105.80 | 95.88 | 68.10 | 82.64 | 204.20 | 94.02 | 195.31 | 183.60 | 156.05 |
Days Payable | 29.35 | 73.18 | 65.39 | 89.93 | 83.26 | 66.57 | 95.04 | 165.91 | 53.15 | 90.04 | 108.69 | 58.19 |
Cash Conversion Cycle | 111.24 | 70.53 | 81.11 | 83.32 | 77.26 | 88.75 | 53.28 | 132.41 | 71.61 | 162.99 | 141.22 | 111.33 |
Working Capital Days | 105.50 | 61.02 | 83.20 | 64.93 | -78.57 | 59.44 | 17.05 | 26.07 | 77.90 | 114.92 | 44.62 | 16.30 |
ROCE % | -10.72% | -29.82% | -17.58% | -16.25% | -12.83% | -11.34% | -20.20% | -3.58% | 17.18% | -3.90% | -12.61% | -7.00% |
Documents
Announcements
- Financial Results For The Period Ended 30Th September, 2024 17 Oct
-
Board Meeting Outcome for Approval Of Un-Audited Financial Statements For The Period Ended 30Th September, 2024
17 Oct - Approved un-audited financial statements for Q2 2024.
-
Board Meeting Intimation for Meeting To Be Held On 17Th October, 2024 To Discuss And Approve Un-Audited Results For The Quarter And Half Year Ended 30Th September, 2024
14 Oct - Board meeting to discuss financial results on 17th October.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct
- Closure of Trading Window 30 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a contract manufacturer of personal care products in India, offering one-stop shop from product conception to finished goods and undertaking private labelling